220927-27-5 Usage
General Description
"(R,E)-(1-{1-{3-[2-(7-Chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propylsulfanylmethyl}cyclopropyl)acetic acid is a complex chemical compound with a long and specific molecular structure. It contains a cyclopropyl group and a combination of various aromatic and aliphatic groups. The compound also contains a quinolin-2-yl group and a hydroxyethyl group, among others. The presence of a sulfanyl and acetic acid group also adds complexity to its structure. Due to its intricate and multifunctional structure, this chemical likely has a diverse range of potential applications in medicine, chemistry, and material science."
Check Digit Verification of cas no
The CAS Registry Mumber 220927-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,9,2 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 220927-27:
(8*2)+(7*2)+(6*0)+(5*9)+(4*2)+(3*7)+(2*2)+(1*7)=115
115 % 10 = 5
So 220927-27-5 is a valid CAS Registry Number.
220927-27-5Relevant articles and documents
Identification, synthesis and characterization of impurities of Montelukast sodium
Sunil Kumar,Anjaneyulu,Hima Bindu
, p. 4536 - 4546 (2012/02/04)
Montelukast sodium is a selective leukotriene receptor antagonist which inhibits cysteinyl leukotriene CysLT1 receptor. Various synthesis of Montelukast is published. During laboratory optimization and later in bulk synthesis formation of various impurities was detected. Besides, pharma Europa draft mention nine process related impurities. However, the method of preparation of most of these impurities is not available in literature. Also, different route of synthesis will have different impurity profile and those process related impurities are not covered in pharmacopeias. In this study we report the synthesis of possible process impurities, including seven impurities (A-H) mentioned in pharma Europa.
